SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-24-000172
Filing Date
2024-02-02
Accepted
2024-02-02 17:02:41
Documents
16
Period of Report
2024-02-02
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cdio_8k.htm   iXBRL 8-K 30921
2 FORM OF WARRANT ex4x1.htm EX-4.1 62788
  Complete submission text file 0001079973-24-000172.txt   331169

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cdio-20240202.xsd EX-101.SCH 3860
4 XBRL DEFINITION FILE cdio-20240202_def.xml EX-101.DEF 26726
5 XBRL LABEL FILE cdio-20240202_lab.xml EX-101.LAB 36860
6 XBRL PRESENTATION FILE cdio-20240202_pre.xml EX-101.PRE 25350
17 EXTRACTED XBRL INSTANCE DOCUMENT cdio_8k_htm.xml XML 5915
Mailing Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645
Business Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645 855-226-9991
Cardio Diagnostics Holdings, Inc. (Filer) CIK: 0001870144 (see all company filings)

IRS No.: 870925574 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41097 | Film No.: 24592527
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)